Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C, Chronic, Healthy Volunteer”

Showing 16 of 0 results

Early research (Phase 1)Ended earlyNCT00439959
What this trial is testing

Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected Adults

Who this might be right for
Hepatitis C, ChronicHepatitis C
GlaxoSmithKline 48
Early research (Phase 1)Study completedNCT01211626
What this trial is testing

Study of ANA773 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) to Assess Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD)

Who this might be right for
HCV Infection
Hoffmann-La Roche 75
Early research (Phase 1)Study completedNCT01907724
What this trial is testing

Drug-Drug Interaction Between IDX719, Simeprevir, TMC647055 and Ritonavir When Administered in Combination in Healthy Participants (MK-1894-007)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 34
Early research (Phase 1)Study completedNCT00314054
What this trial is testing

Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy Adults

Who this might be right for
Hepatitis CHepatic Insufficiency
Wyeth is now a wholly owned subsidiary of Pfizer 27
Testing effectiveness (Phase 2)WithdrawnNCT04309734
What this trial is testing

Study of AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected Subjects

Who this might be right for
Hepatitis CHepatitis C, ChronicChronic Hepatitis C+2 more
Atea Pharmaceuticals, Inc.
Early research (Phase 1)Study completedNCT01523990
What this trial is testing

Evaluate the Safety, Tolerability, and PK in Healthy Volunteers and HCV Genotype 1 Infected Patients

Who this might be right for
HealthyHepatitis C, Chronic
TaiGen Biotechnology Co., Ltd. 135
Early research (Phase 1)Study completedNCT01570244
What this trial is testing

Drug-drug Interaction of BI 201335 and Microgynon

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 16
Early research (Phase 1)Study completedNCT01766167
What this trial is testing

Clinical Pharmacology Study of MP-424

Who this might be right for
Chronic Hepatitis C
Tanabe Pharma Corporation 26
Early research (Phase 1)Study completedNCT01813513
What this trial is testing

Study to Evaluate Drug-Drug Interaction Between IDX719 and Simeprevir in Healthy Participants (MK-1894-004)

Who this might be right for
Chronic Hepatitis C Infection
Merck Sharp & Dohme LLC 42
Testing effectiveness (Phase 2)Ended earlyNCT00229749
What this trial is testing

Study of AVI-4065 in Healthy Volunteers and Chronic Active HCV Patients

Who this might be right for
Hepatitis C
Sarepta Therapeutics, Inc. 80
Early research (Phase 1)Study completedNCT02512562
What this trial is testing

Evaluate the Effect of ACH-3102 and Simeprevir on AL-335 Pharmacokinetics in Healthy Volunteers

Who this might be right for
Chronic Hepatitis C
Alios Biopharma Inc. 32
Early research (Phase 1)Study completedNCT01879462
What this trial is testing

A First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single & Repeat Escalating Doses of GSK2878175 in Healthy Subjects

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 47
Early research (Phase 1)Study completedNCT01813552
What this trial is testing

To Evaluate the Effect of Ritonavir or Omeprazole on the Pharmacokinetics of Samatasvir (IDX719) in Healthy Participants (MK-1894-006)

Who this might be right for
Chronic Hepatitis C Infection
Merck Sharp & Dohme LLC 24
Early research (Phase 1)Ended earlyNCT01554085
What this trial is testing

First in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
Alios Biopharma Inc. 78
Testing effectiveness (Phase 2)UnknownNCT01718834
What this trial is testing

Safety and Efficacy Study of CENV3 Vaccine to Protect Against HCV Infection

Who this might be right for
Vaccine Overdose of Undetermined Intent
National Liver Institute, Egypt 50
Early research (Phase 1)Study completedNCT02339207
What this trial is testing

First in Human Study of AL-335; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

Who this might be right for
Chronic Hepatitis C
Alios Biopharma Inc. 112

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation